N/A
N=48
Topcon 3D OCT-1000 Optical Coherence Tomography System
Retinal Disease · Glaucoma
Bottom Line
View on ClinicalTrials.gov: NCT00792259 ↗Enrolled (actual)
48
Serious AEs
0.0%
Results posted
Jun 2015
Primary outcome: Primary: Precision and Agreement Between the Topcon 3D OCT 1000 and the Identified Predicate Device — 235.0; 236.1; NA; 236.0 µm
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Topcon Medical Systems, Inc.
- Primary completion
- Nov 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Precision and Agreement Between the Topcon 3D OCT 1000 and the Identified Predicate Device |
235.0; 236.1; NA; 236.0; 263.1; NA | — |
Summary
The purpose of this clinical protocol is to perform a comparison of Retinal and Retinal Nerve Fiber Layer (RNFL) thickness measurements between the Topcon 3D-1000 and the identified predicate device. In addition, this protocol performs a comparison of the thickness measurement results from images collected and analyzed with the Zeiss Stratus OCT to images collected with the Zeiss Stratus OCT and imported into the Topcon 3D OCT-1000 StratusViewer for analysis.
Eligibility Criteria
Retinal Disease Study
No Retinal Disease:
Inclusion Criteria
- Male or female
- Between 18 and 80 years of age
- Either eye, but only one eye per subject will be enrolled
- Topcon image quality factor ≥ 45 or Stratus signal strength ≥ 5.
Exclusion Criteria
- Any known ocular disease
- Any systemic disease that could result in ocular manifestations such as hypertension, diabetes, heart disease, etc.
- Topcon image quality factor ≤ 44 or Stratus signal strength < 5.
Retinal Disease
Inclusion Criteria
- Male or female
- Between 18 and 80 years of age
- Either eye, but only one eye per subject will be enrolled
- Symptoms consistent with one of the following retinal diseases: diabetic macular edema, cystoid macular edema, epiretinal membrane, macular hole, wet AMD and dry AMD for which OCT imaging is warranted. At lease one (1) case each of these diseases will be included in the study
- A range of retinal thickness will be included
- Topcon image quality factor ≥ 45 or Stratus signal strength ≥ 5.
Exclusion Criteria
- Presence of glaucoma
- Topcon image quality factor ≤ 44 or Stratus signal strength < 5.
Data sourced from ClinicalTrials.gov (NCT00792259). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.